BioNTech Sues Moderna Over COVID-19 Vaccine Technology Patent

MT Newswires Live

Feb 20

BioNTech (BNTX) sued rival Moderna (MRNA) for allegedly directly and willfully infringing at least one of its patents related to its COVID-19 vaccine technology, according to a lawsuit filed Thursday.

The biotech firm alleged Moderna's mNEXSPIKE COVID-19 vaccine "exploits BioNTech's streamlined, domain-based COVID-19 vaccine technology claimed and protected" by a patent.

Even as Moderna uses the patent technology, the company "has not sought a license from BioNTech," but "profited and will continue to profit from its unauthorized and unlicensed use" of BioNTech's technology, BioNTech said in the lawsuit.

BioNTech demanded it be rewarded "all damages adequate to compensate it for Moderna's infringement" and a jury trial if necessary, according to the lawsuit.

Moderna did not immediately reply to MT Newswires' request for comment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2612317262"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2612317262\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2612317262?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 21:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612317262","market":"sh","top_or_hot":-1,"title":"BioNTech Sues Moderna Over COVID-19 Vaccine Technology Patent","media":"MT Newswires Live","content":"<html><body><p> BioNTech (BNTX) sued rival <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> (MRNA) for allegedly directly and willfully infringing at least one of its patents related to its COVID-19 vaccine technology, according to a lawsuit filed Thursday.</p><p>The biotech firm alleged Moderna's mNEXSPIKE COVID-19 vaccine \"exploits BioNTech's streamlined, domain-based COVID-19 vaccine technology claimed and protected\" by a patent.</p><p>Even as Moderna uses the patent technology, the company \"has not sought a license from BioNTech,\" but \"profited and will continue to profit from its unauthorized and unlicensed use\" of BioNTech's technology, BioNTech said in the lawsuit.</p><p>BioNTech demanded it be rewarded \"all damages adequate to compensate it for Moderna's infringement\" and a jury trial if necessary, according to the lawsuit.</p><p>Moderna did not immediately reply to MT Newswires' request for comment.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech Sues Moderna Over COVID-19 Vaccine Technology Patent</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech Sues Moderna Over COVID-19 Vaccine Technology Patent\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-02-20 21:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> BioNTech (BNTX) sued rival <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> (MRNA) for allegedly directly and willfully infringing at least one of its patents related to its COVID-19 vaccine technology, according to a lawsuit filed Thursday.</p><p>The biotech firm alleged Moderna's mNEXSPIKE COVID-19 vaccine \"exploits BioNTech's streamlined, domain-based COVID-19 vaccine technology claimed and protected\" by a patent.</p><p>Even as Moderna uses the patent technology, the company \"has not sought a license from BioNTech,\" but \"profited and will continue to profit from its unauthorized and unlicensed use\" of BioNTech's technology, BioNTech said in the lawsuit.</p><p>BioNTech demanded it be rewarded \"all damages adequate to compensate it for Moderna's infringement\" and a jury trial if necessary, according to the lawsuit.</p><p>Moderna did not immediately reply to MT Newswires' request for comment.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4534","symbol_name":"瑞士信贷持仓","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2612317262","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2612317262","pubTimestamp":1771592858,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"BioNTech  sued rival Moderna  for allegedly directly and willfully infringing at least one of its patents related to its COVID-19 vaccine technology, according to a lawsuit filed Thursday.The biotech firm alleged Moderna's mNEXSPIKE COVID-19 vaccine \"exploits BioNTech's streamlined, domain-based COVID-19 vaccine technology claimed and protected\" by a patent.Even as Moderna uses the patent technology, the company \"has not sought a license from BioNTech,\" but \"profited and will continue to profit from its unauthorized and unlicensed use\" of BioNTech's technology, BioNTech said in the lawsuit.BioNTech demanded it be rewarded \"all damages adequate to compensate it for Moderna's infringement\" and a jury trial if necessary, according to the lawsuit.Moderna did not immediately reply to MT Newswires' request for comment.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNX":"Defiance Daily Target 2X Long MRNA ETF","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓","BK4535":"淡马锡持仓","BK4588":"碎股","BK4139":"生物科技","BK4532":"文艺复兴科技持仓","MRNY":"MRNA期权收益策略ETF-YieldMax","BK4533":"AQR资本管理(全球第二大对冲基金)","BNTX":"BioNTech SE","BK4501":"段永平概念","BK4551":"寇图资本持仓","BK4568":"美国抗疫概念","MRNA":"Moderna, Inc."},"translate_title":"BioNTech就COVID-19疫苗技术专利起诉Moderna","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNY":0.6,"MRNX":0.6,"MRNA":1,"BNTX":1.5},"content_text":"BioNTech (BNTX) sued rival Moderna (MRNA) for allegedly directly and willfully infringing at least one of its patents related to its COVID-19 vaccine technology, according to a lawsuit filed Thursday.The biotech firm alleged Moderna's mNEXSPIKE COVID-19 vaccine \"exploits BioNTech's streamlined, domain-based COVID-19 vaccine technology claimed and protected\" by a patent.Even as Moderna uses the patent technology, the company \"has not sought a license from BioNTech,\" but \"profited and will continue to profit from its unauthorized and unlicensed use\" of BioNTech's technology, BioNTech said in the lawsuit.BioNTech demanded it be rewarded \"all damages adequate to compensate it for Moderna's infringement\" and a jury trial if necessary, according to the lawsuit.Moderna did not immediately reply to MT Newswires' request for comment.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}